These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1688 related items for PubMed ID: 26281148

  • 21. A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient.
    Fujimoto T, Nakada Y, Yamamoto I, Kobayashi A, Tanno Y, Yamada H, Miki J, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():81-5. PubMed ID: 26031594
    [Abstract] [Full Text] [Related]

  • 22. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.
    Gupta G, Abu Jawdeh BG, Racusen LC, Bhasin B, Arend LJ, Trollinger B, Kraus E, Rabb H, Zachary AA, Montgomery RA, Alachkar N.
    Transplantation; 2014 Jun 27; 97(12):1240-6. PubMed ID: 24937198
    [Abstract] [Full Text] [Related]

  • 23. Outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at King Fahad Specialist Hospital, Dammam, Saudi Arabia.
    Idris MA, Hossain A, Muntasir MA, Marmi A, Aldajani AA, Aljamaan YM, Akhtar M, Housawi A.
    Saudi J Kidney Dis Transpl; 2017 Jun 27; 28(3):499-506. PubMed ID: 28540885
    [Abstract] [Full Text] [Related]

  • 24. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.
    Transplantation; 2013 Jan 27; 95(2):341-6. PubMed ID: 23197178
    [Abstract] [Full Text] [Related]

  • 25. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 27; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Early Intervention in Living Kidney Transplantation Based on Dynamic Monitoring of Donor Specific Antibodies.
    Chen Y, Li LY, Lou XY, Wang H, Zhang L, Zhu YH.
    Clin Transpl; 2014 Oct 27; ():205-8. PubMed ID: 26281146
    [Abstract] [Full Text] [Related]

  • 28. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
    Ashimine S, Watarai Y, Yamamoto T, Hiramitsu T, Tsujita M, Nanmoku K, Goto N, Takeda A, Katayama A, Uchida K, Kobayashi T.
    Kidney Int; 2014 Feb 27; 85(2):425-30. PubMed ID: 23945498
    [Abstract] [Full Text] [Related]

  • 29. Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection.
    Jordan SC, Vo AA, Toyoda M, Tyan D, Nast CC.
    Pediatr Transplant; 2005 Apr 27; 9(2):155-61. PubMed ID: 15787786
    [Abstract] [Full Text] [Related]

  • 30. Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low Titers.
    Kanter Berga J, Sancho Calabuig A, Gavela Martinez E, Puig Alcaraz N, Avila Bernabeu A, Crespo Albiach J, Molina Vila P, Beltrán Catalan S, Pallardó Mateu L.
    Transplant Proc; 2016 Nov 27; 48(9):2880-2883. PubMed ID: 27932097
    [Abstract] [Full Text] [Related]

  • 31. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D, Bach C, Staudner C, Böger CA, Bergler T, Banas B, Spriewald BM.
    Nephrol Dial Transplant; 2017 Apr 01; 32(4):730-737. PubMed ID: 28339671
    [Abstract] [Full Text] [Related]

  • 32. Hidden perils in a highly sensitized kidney transplant recipient.
    Ford S, Summers S, Cantwell L, Mulley W.
    Nephrology (Carlton); 2012 Apr 01; 17 Suppl 1():9-11. PubMed ID: 22497647
    [Abstract] [Full Text] [Related]

  • 33. Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients.
    Peng ZG, Tian J.
    Clin Transpl; 2014 Apr 01; ():209-14. PubMed ID: 26281147
    [Abstract] [Full Text] [Related]

  • 34. Late acute humoral rejection in low-risk renal transplant recipients induced with an interleukin-2 receptor antagonist and maintained with standard therapy: preliminary communication.
    Morales J, Contreras L, Zehnder C, Pinto V, Elberg M, Araneda S, Herzog C, Calabran L, Aguiló J, Ferrario M, Buckel E, Fierro JA.
    Transplant Proc; 2011 Apr 01; 43(6):2295-9. PubMed ID: 21839258
    [Abstract] [Full Text] [Related]

  • 35. Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients.
    Brokhof MM, Sollinger HW, Hager DR, Muth BL, Pirsch JD, Fernandez LA, Bellingham JM, Mezrich JD, Foley DP, D'Alessandro AM, Odorico JS, Mohamed MA, Vidyasagar V, Ellis TM, Kaufman DB, Djamali A.
    Transplantation; 2014 Mar 27; 97(6):612-7. PubMed ID: 24531846
    [Abstract] [Full Text] [Related]

  • 36. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
    Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey D, Milliner D, Graff R, Steiner R, Ciancio G, Sahney S, Light J.
    J Am Soc Nephrol; 2004 Dec 20; 15(12):3256-62. PubMed ID: 15579530
    [Abstract] [Full Text] [Related]

  • 38. Panel-reactive antibody levels and renal transplantation rates in sensitized patients after desensitization and human leucocyte antigen amino acid residue matching.
    Shang W, Dong L, Feng G, Wang Y, Pang X, Li J, Liu L, Zhang W.
    J Int Med Res; 2013 Aug 20; 41(4):1333-41. PubMed ID: 23780877
    [Abstract] [Full Text] [Related]

  • 39. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang X, Wang J, Zhou Z, Zhang Y, Liu H, Tong C, Yu C, Lu Y, Zhao Y, Xiong M, Zhou JR, Juan S, Liu DY, Wei Z, Zhang J, Wu T, Lu DP.
    Clin Transpl; 2014 Aug 20; ():245-50. PubMed ID: 26281152
    [Abstract] [Full Text] [Related]

  • 40. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K, Pall A, Chaballout A, El Gamal H, Al Mana H, Humaidan H, Alzayer F, Al Talhi M.
    Transplant Proc; 2013 May 20; 45(4):1423-6. PubMed ID: 23726587
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 85.